“The United States Food and Drug Administration actually issued the most serious class one recall alert for a very common dialysis treatment,” said Jesse Levine with Med Recall News. “It caused so many health problems that they actually required the treatment to be pulled from the market.”
The common dialysis medication GranuFlo was found to increase bicarbonate levels in the blood, causing a condition called alkalosis. According to the FDA, alkalosis is responsible for the advanced risk of cardiac problems for users of the popular dialysis drug.
In 2011, Fresenius Medical Care (FMC) issued an internal notice to its company-owned clinics, warning of the risks and side effects of GranuFlo. However; they failed to issue warnings to thousands of physicians and clinics not owned by FMC who continued to use their product.
“Dialysis users may be experiencing sudden cardiac problems such as heart injuries, a heart attack, stroke or even cardiac arrest and death,” Levine said. “If you or a loved one relies on dialysis treatments for their health needs, it is important to visit our website and get information about the risk.”
For the last ten years, Med Recall News has been issuing consumer alerts about deadly drugs and posting the information on its free website. Today’s alert for dialysis users can be found online at the www.medrecallnews.com portal.
“We really want people to know the risks from using dialysis and how to get more information if they were harmed by using the dialysis treatment,” Levine said. “If a user suffered a sudden cardiac problem within 24 hours of a dialysis treatment, they or their loved ones really need to check out our website for critical information.”
For more information about the medical risks associated with a very common dialysis treatment, please check out the free information on the Med Recall News website at http://www.medrecallnews.com or simply call 888-722-0396.
-30-
Media Contact:
Jesse Levine
Med Recall News
Phone: 888-722-0396
